141 related articles for article (PubMed ID: 37990583)
21. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children.
Yang Z; McMahon CJ; Smith LR; Bersola J; Adesina AM; Breinholt JP; Kearney DL; Dreyer WJ; Denfield SW; Price JF; Grenier M; Kertesz NJ; Clunie SK; Fernbach SD; Southern JF; Berger S; Towbin JA; Bowles KR; Bowles NE
Circulation; 2005 Sep; 112(11):1612-7. PubMed ID: 16144992
[TBL] [Abstract][Full Text] [Related]
22. Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene.
Balmer C; Ballhausen D; Bosshard NU; Steinmann B; Boltshauser E; Bauersfeld U; Superti-Furga A
Eur J Pediatr; 2005 Aug; 164(8):509-14. PubMed ID: 15889279
[TBL] [Abstract][Full Text] [Related]
23. A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.
Zhang Y; Ren H; Zhou S
Medicine (Baltimore); 2020 Oct; 99(40):e22640. PubMed ID: 33019488
[TBL] [Abstract][Full Text] [Related]
24. Asymptomatic young man with Danon disease.
Kim J; Parikh P; Mahboob M; Arrighi JA; Atalay MK; Rowin EJ; Maron MS
Tex Heart Inst J; 2014 Jun; 41(3):332-4. PubMed ID: 24955057
[TBL] [Abstract][Full Text] [Related]
25. Danon disease presenting with dilated cardiomyopathy and a complex phenotype.
Taylor MRG; Ku L; Slavov D; Cavanaugh J; Boucek M; Zhu X; Graw S; Carniel E; Barnes C; Quan D; Prall R; Lovell MA; Mierau G; Ruegg P; Mandava N; Bristow MR; Towbin JA; Mestroni L;
J Hum Genet; 2007; 52(10):830-835. PubMed ID: 17899313
[TBL] [Abstract][Full Text] [Related]
26. Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation.
Bui YK; Renella P; Martinez-Agosto JA; Verity A; Madikians A; Alejos JC
Pediatr Transplant; 2008 Mar; 12(2):246-50. PubMed ID: 18282207
[TBL] [Abstract][Full Text] [Related]
27. Molecular and histologic insights on early onset cardiomyopathy in Danon disease females.
Fernández L; Casamayor Polo L; Bravo García-Morato M; Enguita Valls AB; Ruiz-Bravo E; Muñoz-Cabello P; Ibáñez K; Rodríguez-Laguna L; Martín-Arenas R; Ortega M; Palomares-Bralo M; Del Pozo Á; García-Guereta L; García-Miñaúr S; Lapunzina P; Vallespín E
Clin Genet; 2021 Mar; 99(3):481-483. PubMed ID: 33226119
[No Abstract] [Full Text] [Related]
28. Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G > A in the LAMP-2 gene.
Fidzianska A; Madej-Pilarczyk A; Walczak E; Kuch M
Neuropediatrics; 2013 Oct; 44(5):276-80. PubMed ID: 23504560
[TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations and MRI features of Danon disease: a case series.
Zhang Y; Zhao R; Yuan Y; Yu Y; Liu B; Li X
BMC Cardiovasc Disord; 2023 Aug; 23(1):397. PubMed ID: 37568080
[TBL] [Abstract][Full Text] [Related]
30. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency.
Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J
Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987
[TBL] [Abstract][Full Text] [Related]
31. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.
Xu J; Wang L; Liu X; Dai Q
Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081
[TBL] [Abstract][Full Text] [Related]
32. Natural history of Danon disease.
Boucek D; Jirikowic J; Taylor M
Genet Med; 2011 Jun; 13(6):563-8. PubMed ID: 21415759
[TBL] [Abstract][Full Text] [Related]
33. Hypertrophic Cardiomyopathy with Unusual Extensive Scarring Pattern: Danon Disease.
Le DD; Alvarez P; Barrios R; Arriaga M; Cherry M; Shah D; Lin CH
Methodist Debakey Cardiovasc J; 2016; 12(4):227-229. PubMed ID: 28289499
[No Abstract] [Full Text] [Related]
34. [Clinical characterization of patients with Danon disease].
He JQ; Wang Y; Meng Y; Chen L; Jiang TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):594-7. PubMed ID: 24284189
[TBL] [Abstract][Full Text] [Related]
35. [Pathological diagnosis of Danon disease by endomyocardial biopsy].
Li Q; Chen D; Shang JF; Lu JY; Kang JR; Lyu J
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1276-1281. PubMed ID: 33287513
[TBL] [Abstract][Full Text] [Related]
36. A Nationwide Survey on Danon Disease in Japan.
Sugie K; Komaki H; Eura N; Shiota T; Onoue K; Tsukaguchi H; Minami N; Ogawa M; Kiriyama T; Kataoka H; Saito Y; Nonaka I; Nishino I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30413001
[TBL] [Abstract][Full Text] [Related]
37. Review: Danon disease: Review of natural history and recent advances.
Cenacchi G; Papa V; Pegoraro V; Marozzo R; Fanin M; Angelini C
Neuropathol Appl Neurobiol; 2020 Jun; 46(4):303-322. PubMed ID: 31698507
[TBL] [Abstract][Full Text] [Related]
38. Fasciculoventricular and atrioventricular accessory pathways in patients with Danon disease and preexcitation: A multicenter experience.
Darden D; Hsu JC; Tzou WS; von Alvensleben JC; Brooks M; Hoffmayer KS; Brambatti M; Sauer WH; Feld GK; Adler E
Heart Rhythm; 2021 Jul; 18(7):1194-1202. PubMed ID: 33737230
[TBL] [Abstract][Full Text] [Related]
39. Heart transplantation in Danon disease: Long term single centre experience and review of the literature.
Di Nora C; Miani D; D'Elia AV; Poli S; Iascone M; Nucifora G; Finato N; Sponga S; Proclemer A; Livi U
Eur J Med Genet; 2020 Feb; 63(2):103645. PubMed ID: 30959184
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular magnetic resonance findings in a case of Danon disease.
Piotrowska-Kownacka D; Kownacki L; Kuch M; Walczak E; Kosieradzka A; Fidzianska A; Krolicki L
J Cardiovasc Magn Reson; 2009 Apr; 11(1):12. PubMed ID: 19402899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
